Genomic Tool Vendors Could Benefit From New International Rare-Disease Consortium
April 12, 2011
Genomic Tool Vendors Could Benefit From New International Rare-Disease Consortium
To support the International Rare Disease Research Consortium, or IRDiRC, the European Commission in July will launch a $140 million call for research proposals. Those familiar with the effort say sequencing- and array-based studies will be favored.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.